Apple files more patents related to wearable smart ring devices.

In this week’s featured patents, we cover the latest patent applications from Apple, Intel, IBM, Microsoft, Boston Scientific, Medtronic, Novartis, and Abbott.

Apple Seeks a Patent for User Interfaces for a Wearable Ring Device

U.S. patent application, 20200241641, discusses a wearable ring device with a display, a touch-sensitive surface, and other sensors for interacting with or controlling external electronic devices. The ring device can be worn on the finger as depicted below.

Intel Files a Patent for User Gesture Directed Object Detection and Recognition in a Vehicle

U.S. patent application, 20200239014, discloses a method for selecting an object using a user’s gesture or eye tracking. The method includes placing a gesture or eye tracker near a user, along with a camera positioned to share a field of view with the user. The user looks at or gestures to an object for selection and performing an action. The illustration below depicts the components of the system.

IBM Wants a Patent for Initiating Actions Responsive to User Expressions While Reading Media Content

U.S. patent application, 20200241638, discloses a method that determines a user’s expression when viewing a portion of a media content presented on a display and automatically presents additional relevant media content based on the expression. The figure below illustrates a pictorial view of a user reading media content presented on an electronic reading device.

Microsoft Seeks a Patent for Preserving Styles and Ink-Effects in Ink-to-Text Conversions

U.S. patent application, 20200242346, describes a method for preserving styles and ink-effects in ink-to-text conversions. When converting ink to text, an ink conversion feature not only identifies characters and words, but also applies styles to the text based on the ink parameters. The ink conversion feature can include font style or ink effect of the ink stroke. An example scenario of preserving ink effects in ink-to-text is depicted below.

Boston Scientific Seeks Patents for a Pain Management System and another for an Ablation System

U.S. patent application, 20200238087, relates to a pain management system comprising sensors for physiological signals indicative of a patient’s brain activity. The system extracts signal metrics indicative of the pattern of brain activity and outputs a pain score for delivering pain therapy to the patient. The figure below shows the pain management system.

Another U.S. patent application, 20200237425, describes a smart power selection method for a multi-electrode ablation system. A graphical user interface in the system displays the number of electrodes of an ablation catheter to be active, and a computing device estimates and assigns an amount of energy to active electrodes. The figure below shows the ablation system.

Medtronic Seeks to Patent a Cerebrospinal Fluid Shunt

U.S. patent application, 20200238061, discloses a shunt for partial implantation into a patient that includes an elongated conduit with a lumen therethrough. The conduit includes a proximal end for receipt of bodily fluids for flow through the shunt and a distal end for discharge of the bodily fluids from the shunt. There is also a long term source of at least one occlusion resistant agent which can permeate through a portion of the elongated conduit. The illustration below depicts the shunt.

Novartis Aims to Patent a Combination Therapy for Cancer

U.S. patent application 20200237874, presents a method of treating cancer that includes specific dosage regimens of IL-15/IL-15Ra in combination with an anti-PD-1 antibody molecule to patients.

Abbott Wants to Patent an Analyte Sensor for Creatinine

U.S. patent application, 20200241015, discloses an analyte sensor with a sensor tail comprising a first working electrode, a creatinine-responsive active area, a first membrane that is permeable to creatinine and overcoats the creatinine-responsive active area, and an oxygen scavenger located upon the sensor tail in proximity to the creatinine-responsive active area. The figure below illustrates the sensing system with an analyte sensor.